At Home Ammonia Monitoring of Inborn Errors of Ammonia Metabolism
Launched by SEQUITUR HEALTH CORP. · Apr 23, 2025
Trial Information
Current as of June 28, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
This clinical trial is looking into how well people with certain ammonia metabolism disorders can measure their ammonia levels at home. Specifically, the study wants to find out if participants will check their ammonia levels every day. If you or a loved one has been diagnosed with specific conditions like urea cycle disorders or organic acidemias, you may be eligible to join the trial. Participants must be confirmed to have one of these conditions, be able to read and understand English, and will not be allowed to join if they have other serious health problems that affect ammonia levels.
If you decide to participate, you’ll need to attend three visits at the clinic. Each day, you will measure your temperature, heart rate, and blood oxygen levels, complete a short survey, and check your ammonia levels at home. This trial is not yet recruiting participants, but it’s an important step in understanding how to better manage ammonia-related health issues at home.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Confirmed ammonia disorder such as
- • Ornithine transcarbamylase deficiency
- • Systemic primary carnitine deficiency
- • Type I citrullinemia
- • Argininosuccinic aciduria
- • Isolated methylmalonic acidemia
- • Type II citrullinemia
- • Propionic acidemia
- • Isovaleric acidemia
- • Multiple acyl-CoA dehydrogenase deficiency
- • Pyruvate carboxylase deficiency
- • Argininemia (arginase deficiency)
- • Carbamoyl phosphate synthase I deficiency
- • Dihydrolipoamide dehydrogenase deficiency
- • Lysinuric protein intolerance
- • Hyperornithinemia-hyperammonemia-homocitrullinuria
- • Carnitine-acylcarnitine translocase deficiency
- • Carbonic anhydrase VA deficiency
- • N-acetyl glutamate synthetase deficiency
- • English Literacy
- Exclusion Criteria:
- • Incarcerated
- • Presence of a non-inborn error of metabolism medical condition associated with abnormal ammonia metabolism (e.g., end stage liver disease).
- • Unable to read in English
About Sequitur Health Corp.
Sequitur Health Corp. is a pioneering clinical trial sponsor dedicated to advancing healthcare through innovative research and development. With a focus on enhancing patient outcomes, Sequitur Health Corp. collaborates with leading medical institutions and experts to design and conduct rigorous clinical trials across various therapeutic areas. The organization is committed to ensuring the highest standards of safety, efficacy, and ethical practice, leveraging cutting-edge technology and data analytics to facilitate the drug development process. By prioritizing patient engagement and transparency, Sequitur Health Corp. strives to bring transformative therapies to market, ultimately improving the quality of life for patients worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Portland, Oregon, United States
Patients applied
Trial Officials
Marylaura L Thomas, Ph.D.
Principal Investigator
Sequitur Health Corp.
Leslie F. Thomas, M.D.
Study Director
Sequitur Health Corp.
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported